key: cord-0698315-butystct
authors: Bienstock, Solomon W.; Tandon, Pranai; Govindarajulu, Usha; Leibner, Evan; Glicksberg, Benjamin S.; Samtani, Rajeev; Giustino, Gennaro; Gidwani, Umesh; Kohli-Seth, Roopa; Goldman, Martin E.
title: Impact of Myocardial Injury in Hospitalized Patients With COVID-19 in 2 Peak Time Periods
date: 2021-10-05
journal: J Am Coll Cardiol
DOI: 10.1016/j.jacc.2021.08.005
sha: ccb22315cf86429b4dd439121c61cc8a7e3442f5
doc_id: 698315
cord_uid: butystct

nan

Myocardial injury is prevalent in patients hospitalized with COVID-19 and has been linked to increased in-hospital mortality, although these data have mostly been gathered early in the pandemic (2, 3) . The aim of this study was to investigate myocardial injury in hospitalized patients with COVID-19 across 2 pre- A total of 7,238 patients were included in the 2 peak time periods (P1, n ¼ 5,698; P2, n ¼ 1,540).

Patients from P1 had higher prevalence of HTN (35% vs 31%; P < 0.001), diabetes (24% vs 20%; P < 0.003), and CKD (12% vs 9.4%; P < 0.002), whereas P2 had more White patients (48% vs 29%; P < 0.001).

Rates of in-hospital mortality and intubation were higher in P1 than P2 (23% vs 13%; P < 0.001; and 12% vs 7.6%; P < 0.001, respectively); however, there was no difference in rates of ICU admission (18% vs 16%; This is the first study to assess the relationship between mortality and myocardial injury across 2 peak time periods of COVID-19. Although mortality was significantly lower in P2, myocardial injury as evidenced by troponin elevation was associated with increased 30-day mortality across both time periods.

Interestingly, although peak troponin elevations during the hospitalization were associated with increased mortality in both time periods, such risk appeared to be greater in P2 compared with P1.

The decreased mortality seen in the pandemic has been reported previously and is possibly related to earlier infection detection, increased testing, novel treatments, viral variants, increased preparedness, and/or lower patient volumes (4) . Even with this decreased mortality, peak troponin was a more robust predictor of mortality in P2 than in P1, whereas P2 had lower troponin elevation when compared with P1.

Possibly, cardiac injury of any degree plays an important role in mortality even in less severe "waves" of this illness. Although earlier detection and novel

An interactive web-based dashboard to track COVID-19 in real time

Characterization of myocardial injury in patients with COVID-19

Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection

Trends in COVID-19 risk-adjusted mortality rates

The authors have reported that they have no relationships relevant to the contents of this paper to disclose. Athena Poppas, MD, served as Guest Editor-in-Chief for this paper. The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors' institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.